SHERRI RICHARDSON: Open Payments
NPI 1164952834 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 28 payments from 14 companies in 2025. Trend: 2023 $1,367 · 2024 $1,586 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $236 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| ABBVIE INC. | 4 | $69 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| Stemline Therapeutics Inc. | 2 | $49 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Incyte Corporation | 1 | $24 |
| KYOWA KIRIN, INC. | 1 | $20 |
Products named: LYNPARZA, KEYTRUDA, EPKINLY, KISQALI, Orserdu, Enhertu, PLUVICTO, JAKAFI.
Industry payments across AL — which companies pay providers there.
